![Agneta Svedberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Agneta Svedberg
Chief Tech/Sci/R&D Officer at
CAMURUS AB
Net worth: 1 M $ as of 31/08/2026
Profile
Agneta Svedberg worked as Manager at Pharmacia & Upjohn, Inc., Principal at Oncotelic Therapeutics, Inc., Senior Vice President-Clinical Development at Genmab, Inc., Chief Operating Officer & Senior Vice President at Zealand Pharma A, and Chief Executive Officer at Cantargia AB. Education includes graduate degree from the University of Lund, MBA from Lund University School of Economics & Management, and MBA from Executive Foundation Lund.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CAMURUS AB 0.04% | 31/12/2025 | 22,987 ( 0.04% ) | 1 M $ | 31/08/2026 |
Agneta Svedberg active positions
| Companies | Position | Start |
|---|---|---|
| CAMURUS AB | Chief Tech/Sci/R&D Officer | 01/01/2019 |
Former positions of Agneta Svedberg
| Companies | Position | End |
|---|---|---|
| CANTARGIA AB | Chief Executive Officer | - |
| ZEALAND PHARMA A/S | Chief Operating Officer | - |
| ONCOTELIC THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Pharmacia & Upjohn, Inc.
 Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Corporate Officer/Principal | - |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Creates and develops human antibodies for the treatment of life-threatening and debilitating diseases | Corporate Officer/Principal | - |
Training of Agneta Svedberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
35
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Pharmacia & Upjohn, Inc.
Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Health Technology |
Oncotelic Therapeutics, Inc.
 Oncotelic Therapeutics, Inc. BiotechnologyHealth Technology Engages in developing novel small-molecule therapeutics to treat cancer and eye diseases | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Camurus AB
 Camurus AB Pharmaceuticals: MajorHealth Technology Provides nanoscale drug delivery systems for development of high value therapeutics | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Creates and develops human antibodies for the treatment of life-threatening and debilitating diseases | Commercial Services |
Cantargia AB
 Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
Lund University School of Economics & Management
 Lund University School of Economics & Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Executive Foundation Lund
 Executive Foundation Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Agneta Svedberg
